(CPS, ). Normally, hyperbilirubinemia resolves on its own as the infant processes the bilirubin and excretes it. However, in some infants, it can become. I was disappointed to see that the statement by the Canadian Paediatric Society ( CPS) on hyperbilirubinemia in term newborn infants did not make more specific. The CPS hyperbilirubinemia guidelines are based on universal predischarge bilirubin screening, and use of a nomogram to guide follow-up and treatment.

Author: Shasida Kazilabar
Country: Armenia
Language: English (Spanish)
Genre: Spiritual
Published (Last): 7 August 2004
Pages: 279
PDF File Size: 16.7 Mb
ePub File Size: 12.28 Mb
ISBN: 975-8-56812-114-7
Downloads: 29894
Price: Free* [*Free Regsitration Required]
Uploader: Malrajas

Double phototherapy with high irradiance compared with single phototherapy in neonates with hyperbilirubinemia. A total of 97 of eligible hospitals responded.

Pediatr Clin North Am ; The CPSP assured the confidentiality of all information provided, since only date of birth and sex were requested. Author information Article notes Copyright and License information Disclaimer.

N Engl J Med ; Canadian Paediatric Surveillance System.

Inthe Canadian Paediatric Society CPS published guidelines on the detection, management and prevention of hyperbilirubinemia aimed at addressing this problem 6. Factors influencing implementation Factors that influenced the decision to implement universal bilirubin screening are summarized in Table 6. Data were collected using an online questionnaire administered using Survey Monkey.

Among these hospitals, hospital-based postdischarge follow-up was reported more frequently than follow-up at community-based locations: Creation of new paediatric or neonatal outpatient clinic.

Although clinical practice guidelines can vps promote evidence-based practice, they are not consistently implemented in an effective and timely manner 10 — The CPS endeavours to provide statements that assist with patient care, and welcomes all comments that serve these efforts.

However, a retrospective review of infants who had phototherapy and a htperbilirubinemia laboratory workup found that The statement Approach to the management of hyperbilirubinemia in term newborn infants was published to sensitize paediatricians to increased reports of kernicterus in North America.

Paediatr Child Health ;9 Suppl A: Reasons hyperbilirrubinemia non-use of proven pharmacotherapeutic interventions: Based on their input, the wording of four questions was revised, additional responses were added to seven multiple choice questions and one question was deleted.


Under-recognition of severe hyperbilirubinemia places otherwise healthy infants at risk for preventable harm 34. Another hospital in the region.

Cost-effectiveness of strategies that are intended to prevent kernicterus in newborn infants.

Evaluation and Treatment of Neonatal Hyperbilirubinemia

Provisional committee for quality improvement and subcommittee on hyperbilirubinemia. One notable trend is that the majority of hospitals in the province have extended their responsibility for babies at higher risk of severe hyperbilirubinemia to include care during the first few days following discharge from hospital. Resistance from care providers huperbilirubinemia screen all babies.

Guidelines for detection, management and prevention of hyperbilirubinemia in term and late preterm newborn infants. Want to use this article elsewhere? Table 5 summarizes hyperbiljrubinemia more common new processes or services that respondents described in open-ended text. Increasing the frequency of breastfeeding decreases the likelihood of significant hyperbilirubinemia. Follow-up for babies requiring repeat bilirubin testing after hospital discharge was organized in a variety of ways.

Evaluation and Treatment of Neonatal Hyperbilirubinemia – – American Family Physician

Journal List Paediatr Child Health v. While some diversity in service delivery models is to be expected given the contextual variations across the province, a provincially coordinated approach to guideline implementation may better support hospitals to benefit from the experiences of others by sharing solutions to challenges, and may also facilitate timelier implementation in low-volume hospitals with limited human resources for guideline implementation.

The authors are also grateful for input provided by Kevin Coughlin, Sandra Dunn, Melissa Dougherty and Jennifer Medves during the development of the survey questionnaire. Interpretation Through this study we systematically estimated the number of infants with severe hyperbilirubinemia in Canada and the underlying causes.

Diagnosis and management of hyperbilirubinemia in the term neonate: N Engl J Med. The high-risk zone is defined by the track of TcB values with positive likelihood ratio greater than 10, and the low-risk zone by the track of TcB values with negative likelihood ratio less than 0.

  CP 341-1CH01-0AE0 PDF

Incidence and causes of severe neonatal hyperbilirubinemia in Canada

In cases Factors influencing best-practice guideline implementation: This element of the guidelines adds complexity to their implementation, given the multiple sectors of the health care system eg, hospitals, community-based care providers and public health involved. Incidence and causes of severe neonatal hyperbilirubinemia in Canada.

Laboratory testing to identity the cause needs to be complete in infants with clinically important hyperbilirubinemia. Hospitals experienced a variety of challenges in implementing the guidelines, and the solutions they developed to address these challenges often involved creating new processes or reorganizing existing services.

All hyperbiligubinemia the authors contributed to the acquisition, analysis and interpretation of the data and to the drafting and revision of the article. A comparison of alternative risk-assessment strategies for predicting significant neonatal hyperbilirubinemia in term and near-term infants. A major limitation of the study was the reliance on self-reported data. The demographic characteristics did not differ significantly between cases with and without a specific diagnosis, although those with no specific diagnosis presented later than infants with an identified cause for the hyperbilirubinemia 4.

A detailed questionnaire, byperbilirubinemia by the research team, was then sent out to those who reported cases in order to gather clinical data and information related to the cause of the hyperbilirubinemia and analyzed by the investigators. This would help to ensure that therapeutic levels of phototherapy are being provided at whatever levels are chosen for treatment. Studies have found that parents of infants with significant jaundice report more separation difficulties and are more likely to bring hyperbilirubine,ia children in for sick visits than parents of infants with similar health status.